409 related articles for article (PubMed ID: 22468856)
21. Gene mutations in retinitis pigmentosa and their clinical implications.
Wang DY; Chan WM; Tam PO; Baum L; Lam DS; Chong KK; Fan BJ; Pang CP
Clin Chim Acta; 2005 Jan; 351(1-2):5-16. PubMed ID: 15563868
[TBL] [Abstract][Full Text] [Related]
22. Clinical and molecular genetic spectrum of autosomal dominant Emery-Dreifuss muscular dystrophy due to mutations of the lamin A/C gene.
Bonne G; Mercuri E; Muchir A; Urtizberea A; Bécane HM; Recan D; Merlini L; Wehnert M; Boor R; Reuner U; Vorgerd M; Wicklein EM; Eymard B; Duboc D; Penisson-Besnier I; Cuisset JM; Ferrer X; Desguerre I; Lacombe D; Bushby K; Pollitt C; Toniolo D; Fardeau M; Schwartz K; Muntoni F
Ann Neurol; 2000 Aug; 48(2):170-80. PubMed ID: 10939567
[TBL] [Abstract][Full Text] [Related]
23. Genetically determined neuromuscular disorders of some Roma families living in Hungary.
Aranka L; Peter M; Jeno K; Katalin R; Gyula T; Emoke E; Agnes H; Tibor H; Laszlo T; Edit B; Marta K; Janos S; Veronika K
Ideggyogy Sz; 2009 Jan; 62(1-2):41-7. PubMed ID: 19248726
[TBL] [Abstract][Full Text] [Related]
24. Mitochondrial cytopathies and neuromuscular disorders.
Van Coster R; De Meirleir L
Acta Neurol Belg; 2000 Sep; 100(3):156-61. PubMed ID: 11098288
[TBL] [Abstract][Full Text] [Related]
25. Muscle MRI in inherited neuromuscular disorders: past, present, and future.
Mercuri E; Pichiecchio A; Allsop J; Messina S; Pane M; Muntoni F
J Magn Reson Imaging; 2007 Feb; 25(2):433-40. PubMed ID: 17260395
[TBL] [Abstract][Full Text] [Related]
26. [The genetic basis of muscle disease].
Bindoff L; Gilhus NE
Tidsskr Nor Laegeforen; 2003 Sep; 123(18):2588-92. PubMed ID: 14714051
[TBL] [Abstract][Full Text] [Related]
27. Molecular diagnosis of inheritable neuromuscular disorders. Part I: Genetic determinants of inherited disease and their laboratory detection.
Greenberg SA; Walsh RJ
Muscle Nerve; 2005 Apr; 31(4):418-30. PubMed ID: 15704142
[TBL] [Abstract][Full Text] [Related]
28. [Screening for hereditary neuromuscular disorders with molecular genetic methods in the Roma population of Hungary].
Herczegfalvi A; Pikó H; Karcagi V
Ideggyogy Sz; 2008 Nov; 61(11-12):426-30. PubMed ID: 19070320
[TBL] [Abstract][Full Text] [Related]
29. Development of a diagnostic genetic test for simplex and autosomal recessive retinitis pigmentosa.
Clark GR; Crowe P; Muszynska D; O'Prey D; O'Neill J; Alexander S; Willoughby CE; McKay GJ; Silvestri G; Simpson DA
Ophthalmology; 2010 Nov; 117(11):2169-77.e3. PubMed ID: 20591486
[TBL] [Abstract][Full Text] [Related]
30. Increasing Role of Titin Mutations in Neuromuscular Disorders.
Savarese M; Sarparanta J; Vihola A; Udd B; Hackman P
J Neuromuscul Dis; 2016 Aug; 3(3):293-308. PubMed ID: 27854229
[TBL] [Abstract][Full Text] [Related]
31. [Molecular genetics of hemophilia A].
De Brasi CD; Slavutsky IR; Larripa IB
Medicina (B Aires); 1996; 56(5 Pt 1):509-17. PubMed ID: 9239887
[TBL] [Abstract][Full Text] [Related]
32. Chromosome 9p-linked families with frontotemporal dementia associated with motor neuron disease.
Le Ber I; Camuzat A; Berger E; Hannequin D; Laquerrière A; Golfier V; Seilhean D; Viennet G; Couratier P; Verpillat P; Heath S; Camu W; Martinaud O; Lacomblez L; Vercelletto M; Salachas F; Sellal F; Didic M; Thomas-Anterion C; Puel M; Michel BF; Besse C; Duyckaerts C; Meininger V; Campion D; Dubois B; Brice A;
Neurology; 2009 May; 72(19):1669-76. PubMed ID: 19433740
[TBL] [Abstract][Full Text] [Related]
33. Utility of next generation sequencing in genetic diagnosis of early onset neuromuscular disorders.
Chae JH; Vasta V; Cho A; Lim BC; Zhang Q; Eun SH; Hahn SH
J Med Genet; 2015 Mar; 52(3):208-16. PubMed ID: 25635128
[TBL] [Abstract][Full Text] [Related]
34. Next generation sequencing in a large cohort of patients presenting with neuromuscular disease before or at birth.
Todd EJ; Yau KS; Ong R; Slee J; McGillivray G; Barnett CP; Haliloglu G; Talim B; Akcoren Z; Kariminejad A; Cairns A; Clarke NF; Freckmann ML; Romero NB; Williams D; Sewry CA; Colley A; Ryan MM; Kiraly-Borri C; Sivadorai P; Allcock RJ; Beeson D; Maxwell S; Davis MR; Laing NG; Ravenscroft G
Orphanet J Rare Dis; 2015 Nov; 10():148. PubMed ID: 26578207
[TBL] [Abstract][Full Text] [Related]
35. A practical approach to molecular diagnostic testing in neuromuscular diseases.
Arnold WD; Flanigan KM
Phys Med Rehabil Clin N Am; 2012 Aug; 23(3):589-608. PubMed ID: 22938877
[TBL] [Abstract][Full Text] [Related]
36. Histochemical and immunohistological approach to comparative neuromuscular diseases.
Paciello O; Papparella S
Folia Histochem Cytobiol; 2009; 47(2):143-52. PubMed ID: 19995699
[TBL] [Abstract][Full Text] [Related]
37. A new paradigm emerges from the study of de novo mutations in the context of neurodevelopmental disease.
Ku CS; Polychronakos C; Tan EK; Naidoo N; Pawitan Y; Roukos DH; Mort M; Cooper DN
Mol Psychiatry; 2013 Feb; 18(2):141-53. PubMed ID: 22641181
[TBL] [Abstract][Full Text] [Related]
38. The genetic basis of neuromuscular disorders.
Nawrotzki R; Blake DJ; Davies KE
Trends Genet; 1996 Aug; 12(8):294-8. PubMed ID: 8783938
[TBL] [Abstract][Full Text] [Related]
39. New diagnostic and therapeutic modalities in neuromuscular disorders in children.
Chikkannaiah M; Reyes I
Curr Probl Pediatr Adolesc Health Care; 2021 Jul; 51(7):101033. PubMed ID: 34281812
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]